These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2898087)

  • 1. Desferrioxamine, anaemia, and haemodialysis.
    Lancet; 1988 Jun; 1(8599):1405-6. PubMed ID: 2898087
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of desferrioxamine on anaemia of haemodialysis patients.
    Felipe C; Rivera M; Orofino L; Matesanz R; Ortuño J
    Nephrol Dial Transplant; 1988; 3(1):105-106. PubMed ID: 3132633
    [No Abstract]   [Full Text] [Related]  

  • 3. Desferrioxamine improves anaemia in haemodialysis patients without aluminum or iron overload.
    Cuvelier R; Deceuninck P
    Nephrol Dial Transplant; 1988; 3(1):104. PubMed ID: 3132631
    [No Abstract]   [Full Text] [Related]  

  • 4. Desferrioxamine does not improve aluminium-unrelated anaemia of haemodialysis.
    Basile C; Scatizzi A
    Nephrol Dial Transplant; 1988; 3(3):355. PubMed ID: 3140114
    [No Abstract]   [Full Text] [Related]  

  • 5. Desferrioxamine versus erythropoietin for treatment of dialysis anaemia.
    Padovese P; Gallieni M; Galmozzi C; Brancaccio D
    Lancet; 1990 Jun; 335(8703):1465. PubMed ID: 1972238
    [No Abstract]   [Full Text] [Related]  

  • 6. Microcytic anemia in dialysis patients.
    Grossman SD; Smith LE
    Am J Kidney Dis; 1988 Apr; 11(4):362. PubMed ID: 3354574
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement in the erythropoiesis of chronic haemodialysis patients with desferrioxamine.
    de la Serna FJ; Praga M; Gilsanz F; Rodicio JL; Ruilope LM; Alcazar JM
    Lancet; 1988 May; 1(8593):1009-11. PubMed ID: 2896866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of the normochromic normocytic anaemia of chronic renal failure to desferrioxamine.
    O'Brien AA; Moore DP; Keogh JA
    Ir J Med Sci; 1987 Aug; 156(8):236-7. PubMed ID: 3667188
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement of anaemia with desferrioxamine in haemodialysis patients.
    Praga M; Andrés A; de la Serna J; Ruilope LM; Nieto J; Estenoz J; Millet VG; Arnaiz F; Rodicio JL
    Nephrol Dial Transplant; 1987; 2(4):243-7. PubMed ID: 3118265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of haemodialysis-associated anaemia by deferoxamine. Effects on serum aluminum and iron overload.
    von Bonsdorff M; Sipilä R; Pitkänen E
    Scand J Urol Nephrol Suppl; 1990; 131():49-54. PubMed ID: 2075470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of fluoxymesterone on anaemia in chronic haemodialysis--special reference to combination therapy with iron (author's transl)].
    Kataoka Y
    Horumon To Rinsho; 1981 Jun; 29(6):675-82. PubMed ID: 7318194
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaemia and aluminium chelation therapy in dialysis patients.
    Tielemans C; Collart F; Wens R; Smeyers-Verbeeke J; Van Hooff I; Dratwa M; Verbeelen D
    Lancet; 1988 Jul; 2(8604):220. PubMed ID: 2899690
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
    Mudde AH; Roodvoets AP; Van Groningen K
    Neth J Med; 1985; 28(1):6-11. PubMed ID: 3974771
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P; Ralston AJ; Day JP
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications for desferrioxamine in patients with chronic renal insufficiency treated by dialysis].
    Simon P
    Nephrologie; 1986; 7(5):177-80. PubMed ID: 3822038
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferrioxamine.
    Giordano N; Fioravanti A; Sancasciani S; Marcolongo R; Borghi C
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):961-2. PubMed ID: 6435741
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hemodialysis hemosiderosis with desferrioxamine.
    Rembold CM; Krumlovsky FA; Roxe DM; Fitzsimmons E; del Greco F
    Trans Am Soc Artif Intern Organs; 1982; 28():621-6. PubMed ID: 7164314
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy.
    Abreo K; Brown ST; Sella M; Trapp G
    J Lab Clin Med; 1989 Jan; 113(1):50-7. PubMed ID: 2909650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in bone histology after treatment with desferrioxamine.
    Ott SM; Andress DL; Nebeker HG; Milliner DS; Maloney NA; Coburn JW; Sherrard DJ
    Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.